{
    "2021-07-07": [
        [
            {
                "time": "",
                "orginal_text": "7.19亿，仁和拿下多家企业",
                "features": {
                    "keywords": [
                        "仁和",
                        "企业收购",
                        "资金规模"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "中银基金旗下部分产品二季报出炉，个别债基标的受监管处罚，刘潇大幅加仓云南白药、丽珠集团、大参林",
                "features": {
                    "keywords": [
                        "中银基金",
                        "二季报",
                        "监管处罚",
                        "云南白药",
                        "丽珠集团",
                        "大参林"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "电报|中银基金首家公布二季报中银医疗保健第一重仓云南白药",
                "features": {
                    "keywords": [
                        "中银基金",
                        "二季报",
                        "中银医疗保健",
                        "云南白药"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "医药行业周报：《2021年国家医保药品目录调整工作方案》出炉 重点关注意创新药投资机会",
                "features": {
                    "keywords": [
                        "医药行业",
                        "医保药品目录",
                        "创新药",
                        "政策调整"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}